On June 9, Yiming Enke announced on the Hong Kong Stock Exchange that Dr. Wu Zhuli was appointed as the Group's Chief Medical Officer, responsible for the construction and management of the company's clinical team, clinical trial research, and clinical development and registration.

Zhitongcaijing · 06/09 11:25
On June 9, Yiming Enke announced on the Hong Kong Stock Exchange that Dr. Wu Zhuli was appointed as the Group's Chief Medical Officer, responsible for the construction and management of the company's clinical team, clinical trial research, and clinical development and registration.